Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,133 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06448403Recruiting
Alzheimer's assessment study with brain scans
This study uses brain scans (MRI and EEG) to better understand Alzheimer's disease. It compares people with MCI or Alzheimer's to healthy volunteers to see how the disease affects the brain.
Trondheim, TrønderlagAges 65 years+ - NCT06448390Recruiting
Exercise study for leg pain from blocked arteries
This trial tests if a supervised exercise program can improve walking ability in people with leg pain caused by blocked arteries (claudication). You may qualify if you have calf pain after walking short distances that goes away with rest.
ÅlesundAges 18 years+ - NCT06449547Recruiting
Risk factors for anxiety and depression in shingles nerve pain
This study looks at what makes people with shingles nerve pain more likely to feel anxious or depressed. By joining, you'll help doctors understand how to better support patients like you.
Wuhan, HubeiAges 18 years+ - NCT06453928Recruiting
Starting technology for high-risk type 1 diabetes
This study tests a new approach to help people with type 1 diabetes who have high blood sugar (A1c above 8.5%) and are not on an insulin pump. It looks at whether using diabetes technology can improve your glucose control.
Santa Monica, CaliforniaAges 18 years+ - NCT06459778Recruiting
A new lab method to help eggs develop in IVF for women 35–42
This study is testing a special lab technique called Piezo-ICSI to see if it can improve the chances of a fertilized egg developing normally in women ages 35–42 who are going through IVF or ICSI. It may help if you've had fewer than 3 previous cycles and don’t have certain uterine or genetic issues.
Nanjing, JiangsuAges 35–42 - NCT06460012Recruiting
Phone support for dementia caregivers (living & learning)
This study tests a support program delivered by phone to help caregivers of people with Alzheimer's or dementia manage challenging behaviors and reduce their own stress. You'll receive coaching and resources, answer surveys, and learn practical strategies.
Portland, OregonAges 18 years+ - NCT06463847RecruitingPhase 1
Stem cell therapy for knee osteoarthritis
This trial tests a new stem cell treatment (UC-MSCs) for knee osteoarthritis. It aims to see if this treatment is safe and can help reduce pain and improve knee function.
Wuhan, HubeiAges 50–70 - NCT06466460Recruiting
Interactive bike for quality of life in memory loss
This study tests if using a special interactive stationary bike can improve quality of life for older adults with memory or thinking problems who live in nursing homes. You would be asked to pedal the bike a few times, and the program makes it fun and engaging.
ÖrebroAges 65 years+ - NCT06472908RecruitingPhase 3
Colchicine after stent procedure for heart disease
This trial tests whether colchicine (a medicine used for gout) can help prevent heart problems after a stent procedure (PCI). It's for people who are in the hospital getting a stent and follow standard heart care.
Lanzhou, GansuAges 18–80 - NCT06481943Recruiting
Testing a new heart scan for blocked arteries
This study tests a new magnetic heart scan (MCG) to see if it can better detect blocked arteries causing chest pain or heart attacks. It may help doctors decide the best treatment for you.
Rochester, MinnesotaAges 18 years+ - NCT06484829RecruitingPhase 1/Phase 2
New drug combo for relapsed or refractory multiple myeloma
This trial tests a new drug, purinostat mesylate, combined with pomalidomide (a chemotherapy pill) and a low-dose steroid (dexamethasone) for people with multiple myeloma that has returned or stopped responding to prior treatments. The goal is to see if this combination can help control the cancer with manageable side effects.
Chengdu, SichuanAges 18–75 - NCT07671131Recruiting
Chatbot for helping people who feel little pleasure or joy
This trial tests if a chatbot can improve emotional responses for people with anhedonia (reduced ability to feel pleasure). You will interact with the chatbot and may have brain scans to see changes.
Chengdu, SichuanAges 18–40 - NCT07665242Recruiting
Chatbot therapy for anhedonia and depression
This study tests whether a chatbot-based therapy can help people who feel low pleasure or interest (anhedonia) and depression. It uses brain scans to see how the brain responds to rewards and social situations.
Chengdu, SichuanAges 18–40 - NCT07663019Recruiting
Can a chatbot help with anhedonia and depression?
This study tests whether a friendly chatbot can help people with anhedonia (loss of pleasure) and depression update their beliefs in a more positive way. You'll interact with the chatbot and may have an MRI scan to see how your brain responds.
Chengdu, SichuanAges 18–40 - NCT07665216Recruiting
Chatbot for anhedonia and depression
This study tests whether a chatbot-based intervention can improve brain function and reduce symptoms in people who feel very little pleasure or interest (anhedonia) and have depression. You would have MRI scans to see how your brain responds.
Chengdu, SichuanAges 18–40 - NCT07432334RecruitingPhase 1
CAR T-cell therapy for hard-to-treat lupus
This trial tests a personalized treatment called CD19 CAR T-cell therapy for people with severe lupus that hasn't improved with standard treatments. It uses your own immune cells to target and destroy the faulty cells causing lupus symptoms.
HanoiAges 16–55 - NCT06487429RecruitingPhase 2
Short radiation followed by combo therapy for HER2+ stomach cancer
This trial tests a new approach for stomach cancer that has spread to nearby tissues but not to other organs. You would get a short course of radiation, followed by a combination of targeted therapy (Disitamab Vedotin), chemotherapy (S-1), and immunotherapy (Sintilimab) before surgery to shrink the tumor and improve outcomes.
Wuhan, HubeiAges 18–75 - NCT06491472RecruitingPhase 2
Ivonescimab with radiation and chemo for pancreatic cancer
This trial tests a new immunotherapy drug (ivonescimab) combined with targeted radiation and chemotherapy for people with pancreatic cancer. The goal is to see if this combination can shrink tumors and improve outcomes.
WuhanAges 18 years+ - NCT06495970Recruiting
Pulmonary artery denervation for heart failure with lung hypertension
This trial tests a procedure called pulmonary artery denervation (PADN) for people with heart failure and a certain type of high blood pressure in the lungs (pulmonary hypertension Group 2). The goal is to see if using a special device called the Gradient Denervation System can help control the high pressures and improve your symptoms.
BadalonaAges 22–85 - NCT06500312Recruiting
Lung cancer imaging and genetics study
This study looks at how CT scans of lung cancer can be linked to the tumor's biology and genetics. It aims to understand lung cancer better by combining imaging with lab results.
Wuhan, HubeiAges 18 years+ - NCT06500988Recruiting
Smartphone app for atrial fibrillation and weight management
This study uses a smartphone app and activity tracker to help people with atrial fibrillation (an irregular heartbeat) and a higher body weight manage their condition through tailored exercise guidance.
Baltimore, MarylandAges 18 years+ - NCT06501599Recruiting
AI system for spotting COVID-19 lung changes on CT scans
This trial tests an artificial intelligence tool that helps doctors identify lung changes caused by viral pneumonia, like COVID-19, on CT scans. It may lead to faster and more accurate diagnosis for patients.
MoscowAges 18 years+ - NCT06502275Recruiting
Nutrition and Exercise for Older Colorectal Cancer Patients
This trial tests a nutrition and exercise program designed for older adults with colorectal cancer. It uses a smartphone app to help you stay active and eat well at home.
Chiayi CityAges 60 years+ - NCT06503094RecruitingPhase 1/Phase 2
CAR T cells targeting CD19 and CD20 for relapsed B-cell cancers
This trial tests a new type of CAR T-cell therapy that targets two markers (CD19 and CD20) on B-cell cancer cells. It is for people whose B-cell leukemia or lymphoma has come back or not responded to standard treatments.
Wuhan, HubeiAges 14–75
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,133 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.